Business Wire
18 Nov 2026, 07:23 UTC · 5h ago
Investor Alert: Robbins LLP Informs Investors of the EyePoint, Inc. Class Action Lawsuit
Impact · against what's priced in
EyePoint faces potential legal and financial headwinds following a class action lawsuit alleging the company misled investors about DURAVYU's efficacy. This introduces new litigation risk and calls into question the viability of the company's primary product candidate.
- EYPT−0.40
No priced-in read yet





